HRP20182139T1 - Antifungalna sredstva - Google Patents

Antifungalna sredstva

Info

Publication number
HRP20182139T1
HRP20182139T1 HRP20182139TT HRP20182139T HRP20182139T1 HR P20182139 T1 HRP20182139 T1 HR P20182139T1 HR P20182139T T HRP20182139T T HR P20182139TT HR P20182139 T HRP20182139 T HR P20182139T HR P20182139 T1 HRP20182139 T1 HR P20182139T1
Authority
HR
Croatia
Prior art keywords
antifungal means
antifungal
Prior art date
Application number
HRP20182139TT
Other languages
English (en)
Croatian (hr)
Inventor
Graham Edward Morris SIBLEY
Derek Law
Jason David Oliver
Michael Birch
Original Assignee
F2G Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1420743.5A external-priority patent/GB201420743D0/en
Priority claimed from GBGB1505891.0A external-priority patent/GB201505891D0/en
Application filed by F2G Limited filed Critical F2G Limited
Publication of HRP20182139T1 publication Critical patent/HRP20182139T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G7/00Botany in general
    • A01G7/06Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/601,4-Diazines; Hydrogenated 1,4-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Forests & Forestry (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HRP20182139TT 2014-11-21 2015-11-20 Antifungalna sredstva HRP20182139T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1420743.5A GB201420743D0 (en) 2014-11-21 2014-11-21 Antifungal agents
GBGB1505891.0A GB201505891D0 (en) 2015-04-07 2015-04-07 Antifungal agents
PCT/GB2015/053546 WO2016079536A1 (en) 2014-11-21 2015-11-20 Antifungal agents
EP15800925.8A EP3221308B1 (en) 2014-11-21 2015-11-20 Antifungal agents

Publications (1)

Publication Number Publication Date
HRP20182139T1 true HRP20182139T1 (hr) 2019-05-03

Family

ID=54704024

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20182139TT HRP20182139T1 (hr) 2014-11-21 2015-11-20 Antifungalna sredstva

Country Status (20)

Country Link
US (3) US10201524B2 (enExample)
EP (2) EP3415511A1 (enExample)
JP (1) JP6681894B2 (enExample)
KR (1) KR102550341B1 (enExample)
CN (2) CN107207470B (enExample)
AU (1) AU2015348043B2 (enExample)
BR (1) BR112017010439B1 (enExample)
CA (1) CA2982660C (enExample)
CY (1) CY1120907T1 (enExample)
DK (1) DK3221308T3 (enExample)
ES (1) ES2694637T3 (enExample)
HR (1) HRP20182139T1 (enExample)
IL (1) IL252368B (enExample)
LT (1) LT3221308T (enExample)
MX (1) MX2017006447A (enExample)
PL (1) PL3221308T3 (enExample)
PT (1) PT3221308T (enExample)
RU (1) RU2727520C2 (enExample)
SI (1) SI3221308T1 (enExample)
WO (1) WO2016079536A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
EP3415511A1 (en) 2014-11-21 2018-12-19 F2G Limited Antifungal agents
US9973887B2 (en) * 2016-01-21 2018-05-15 Google Llc Sharing navigation data among co-located computing devices
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
GB201609222D0 (en) * 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
KR20240110109A (ko) 2017-04-10 2024-07-12 싸이넥시스, 인크. 조합하여 사용되는 항진균제
JP2021505660A (ja) 2017-11-30 2021-02-18 ボラゲン,インコーポレーテッド ベンゾキサボロール化合物およびその配合物
CN112867494A (zh) 2018-08-18 2021-05-28 博瑞金股份有限公司 取代苯并氧杂硼杂环戊烯的固体形式和其组合物
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
JP2023527219A (ja) 2020-05-29 2023-06-27 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィック 抗真菌プロドラッグ
CN112358974B (zh) * 2020-12-09 2022-06-10 昆明理工大学 一株植物内生真菌黑附球菌fzt214及其应用
CN114644634B (zh) * 2020-12-21 2023-06-20 深圳市祥根生物医药有限公司 一种吡咯衍生物及其制备方法和用途
CN115109040A (zh) * 2021-03-23 2022-09-27 博瑞生物医药(苏州)股份有限公司 抗真菌化合物,包含其的药物组合物和制剂,及其应用
CN113429396A (zh) * 2021-06-08 2021-09-24 深圳市祥根生物医药有限公司 一种五元杂芳环衍生物及其制备方法和用途
TW202521521A (zh) * 2023-08-08 2025-06-01 大陸商上海森輝醫藥有限公司 一種4-苯基哌啶衍生物及其應用

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202654A (en) 1962-04-27 1965-08-24 Bristol Myers Co 6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
GB1051723A (enExample) 1962-04-27
US3252970A (en) 1963-02-27 1966-05-24 Ciba Geigy Corp Aromatization
BE631632A (enExample) 1963-04-26
US3268558A (en) 1964-11-05 1966-08-23 Ortho Pharma Corp 1-r-2, 4-dinitropyrroles
US3458515A (en) 1966-07-21 1969-07-29 American Home Prod Piperazine substituted pyrroles
GB1208014A (en) 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
US3573294A (en) 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
BE790747A (fr) 1971-10-30 1973-02-15 Whitefin Holding Sa Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
GB1476503A (en) 1973-06-21 1977-06-16 Sterling Drug Inc 1-arylamino-and 1-arylimino-pyrroles and preparation thereof
BE848465A (fr) 1976-11-18 1977-03-16 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
US4316900A (en) 1977-10-05 1982-02-23 Ciba-Geigy Corporation Piperazinopyrrolobenzodiazepines
JPS57142966A (en) 1981-02-27 1982-09-03 Sagami Chem Res Center (1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
JPS57144255A (en) 1981-03-03 1982-09-06 Sagami Chem Res Center Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
US4761424A (en) 1985-10-01 1988-08-02 Warner-Lambert Company Enolamides, pharmaceutical compositions and methods for treating inflammation
FR2601368B1 (fr) 1986-07-08 1989-04-07 Synthelabo Derives de nitrofuranne, leur preparation et leur application en therapeutique.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5637592A (en) 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
HUT77867A (hu) 1994-07-21 1998-09-28 Eli Lilly And Co. sPLA2-gátló indolizinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
EP0823423B1 (en) 1995-04-28 2004-06-16 Banyu Pharmaceutical Co., Ltd. 1,4-disubstituted piperidine derivatives
EP0747756B1 (en) 1995-06-06 2000-05-24 Agfa-Gevaert N.V. Photographic materials
JPH09249669A (ja) 1996-03-13 1997-09-22 Ono Pharmaceut Co Ltd 縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
DK1024814T3 (da) * 1997-10-22 2008-01-02 Jens Ponikau Anvendelse af antisvampemidler til topisk behandling af svampe-induceret mucositis
KR20010052487A (ko) 1998-06-03 2001-06-25 쥐피아이 엔아이엘 홀딩스 인코포레이티드 신경계 질환 및 탈모 치료에 사용되는 아자-헤테로고리화합물
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
CA2372691C (en) 1999-05-04 2009-11-17 Janssen Pharmaceutica N.V. Antifungal ethers
AU6438800A (en) 1999-07-30 2001-02-19 Norbert Heske Cannula system for introducing endoscopic tools in a human or animal body
GB0011089D0 (en) 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (11)
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
US6825201B2 (en) 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
WO2002098876A1 (en) 2001-06-06 2002-12-12 Vertex Pharmaceuticals Incorporated Cak inhibitors and uses thereof
CA2451605C (en) 2001-06-20 2010-08-10 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
US20040162298A1 (en) 2002-02-23 2004-08-19 Hsu-Tso Ho Method of treating HIV infection by preventing interaction of CD4 and gp120
US20050032871A1 (en) 2002-09-03 2005-02-10 Sugen, Inc. Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
AU2004222387A1 (en) 2003-03-13 2004-09-30 Synta Pharmaceuticals Corp. Fused pyrrole compounds
AU2004284084A1 (en) 2003-10-24 2005-05-06 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer
US20060058286A1 (en) 2004-09-16 2006-03-16 Mark Krystal Methods of treating HIV infection
NZ562034A (en) 2005-03-31 2009-10-30 Janssen Pharmaceutica Nv Bicyclic pyrazole compounds as antibacterial agents
AR053713A1 (es) 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
CA2608977C (en) * 2005-05-18 2014-09-23 F2G Ltd Antifungal agents
EP1907347A2 (en) 2005-07-12 2008-04-09 Arcadia Pharmaceuticals Inc. Compounds with activity at retinoic acid receptors
WO2007015866A2 (en) 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
FR2901144B1 (fr) 2006-05-16 2008-12-26 Diffusion Tech Francaise Sarl Appareils generateur d'aerosols medicaux incluant un dispositif d'amelioration de l'efficacite de depot d'aerosol
WO2008046082A2 (en) 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Use of heterocyclic compounds as therapeutic agents
GB0623209D0 (en) 2006-11-21 2007-01-03 F2G Ltd Antifungal agents
CN101260086B (zh) 2007-03-06 2011-08-10 中国科学院上海药物研究所 蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
GB0710121D0 (en) * 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
WO2009129301A2 (en) 2008-04-15 2009-10-22 Schering Corporation Oral pharmaceutical compositions in a molecular solid dispersion
PL2283006T3 (pl) 2008-04-24 2015-08-31 F2G Ltd Pirolowe środki przeciwgrzybicze
GB0809773D0 (en) * 2008-05-29 2008-07-09 F2G Ltd Antifungal combination therapy
EA201101568A1 (ru) 2009-04-28 2012-05-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta
JPWO2012060448A1 (ja) 2010-11-05 2014-05-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
EP3415511A1 (en) 2014-11-21 2018-12-19 F2G Limited Antifungal agents

Also Published As

Publication number Publication date
EP3221308B1 (en) 2018-09-19
KR20170102241A (ko) 2017-09-08
CN111096967A (zh) 2020-05-05
AU2015348043A1 (en) 2017-06-08
CA2982660A1 (en) 2016-05-26
US20170340607A1 (en) 2017-11-30
BR112017010439A2 (pt) 2017-12-26
CY1120907T1 (el) 2019-12-11
SI3221308T1 (sl) 2018-12-31
EP3415511A1 (en) 2018-12-19
US10201524B2 (en) 2019-02-12
KR102550341B1 (ko) 2023-06-30
LT3221308T (lt) 2018-12-27
CN107207470A (zh) 2017-09-26
RU2017121370A3 (enExample) 2019-03-28
US10596150B2 (en) 2020-03-24
CA2982660C (en) 2023-01-24
US11065228B2 (en) 2021-07-20
MX2017006447A (es) 2018-01-30
PT3221308T (pt) 2018-12-17
PL3221308T3 (pl) 2019-03-29
EP3221308A1 (en) 2017-09-27
US20200179340A1 (en) 2020-06-11
JP2017536371A (ja) 2017-12-07
RU2727520C2 (ru) 2020-07-22
CN111096967B (zh) 2023-03-10
ES2694637T3 (es) 2018-12-26
WO2016079536A1 (en) 2016-05-26
US20190314333A1 (en) 2019-10-17
IL252368B (en) 2020-04-30
AU2015348043B2 (en) 2019-08-22
BR112017010439B1 (pt) 2023-03-07
IL252368A0 (en) 2017-07-31
DK3221308T3 (en) 2018-12-10
CN107207470B (zh) 2019-12-03
RU2017121370A (ru) 2018-12-21
JP6681894B2 (ja) 2020-04-15

Similar Documents

Publication Publication Date Title
FIC20250036I1 (fi) Epkoritamabi
FIC20240015I1 (fi) Zilbrysq - tsilukoplaani
FIC20220017I1 (fi) Lonapegsomatropiini
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3006072T3 (da) Karadgang
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
DK3119396T3 (da) Muscarinreceptoragonister
HRP20182139T1 (hr) Antifungalna sredstva
FIC20230016I1 (fi) Nirsevimabi
FIC20240047I1 (fi) Frukintinibi
DK3183340T3 (da) Termolabile exonukleaser
HUE048685T2 (hu) Antimikotikus vegyület
DE112015005041A5 (de) Gargerätevorrichtung
DK3110439T3 (da) Pcsk9-vacciner
DK3009858T3 (da) Skyradar
FI20145913A (fi) Staattorimekanismi
DE112015001633A5 (de) Betätigungsaktuator
DK3447493T3 (da) Proteinrettede ortologer
DE202014005655U8 (de) llluminationsvorrichtung
DE112015005055A5 (de) Gargerätevorrichtung
DK3091875T3 (da) Vipbar taburet
FI20146001A (fi) Tahnatuubin puristin
DK3191825T3 (da) Kreatininbiosensor
FI10894U1 (fi) Putkieristyskouru